Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 01, 2016	Sep. 25, 2015
Current assets:
Cash and cash equivalents	$ 599,991	$ 531,926
Restricted cash	5,673	2,936
Short-term investments	118,778	138,901
Accounts receivable, net of allowance for doubtful accounts of $2,534 and $1,542	91,637	101,563
Inventories	18,544	13,872
Prepaid expenses and other current assets	37,306	32,031
Total current assets	871,929	821,229
Long-term investments	266,431	321,015
Property, plant and equipment, net	428,225	403,091
Intangible assets, net	222,868	127,507
Goodwill	309,020	307,708
Deferred taxes	149,633	143,279
Other non-current assets	15,247	9,464
Total assets	2,263,353	2,133,293
Current liabilities:
Accounts payable	14,762	20,710
Accrued liabilities	174,573	169,307
Income taxes payable	212	754
Deferred revenue	22,530	18,910
Total current liabilities	212,077	209,681
Long-term deferred revenue	34,903	30,581
Other non-current liabilities	76,053	77,024
Total liabilities	323,033	317,286
Stockholders' equity:
Additional paid-in capital	15,380	17,571
Retained earnings	1,926,528	1,800,857
Accumulated other comprehensive (loss)	(10,205)	(11,462)
Total stockholders’ equity – Dolby Laboratories, Inc.	1,931,805	1,807,068
Controlling interest	8,515	8,939
Total stockholders’ equity	1,940,320	1,816,007
Total liabilities and stockholders’ equity	2,263,353	2,133,293
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 54,978,917 shares issued and outstanding at July 1, 2016 and 50,291,426 at September 25, 2015
Stockholders' equity:
Common stock	56	51
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 45,888,962 shares issued and outstanding at July 1, 2016 and 50,743,311 at September 25, 2015
Stockholders' equity:
Common stock	$ 46	$ 51